Zobrazeno 1 - 10
of 32
pro vyhledávání: '"G. Caleb Alexander"'
Autor:
Rachel H. Alinsky, Laura Prichett, Hsien-Yen Chang, G. Caleb Alexander, Bradley D. Stein, Brendan Saloner
Publikováno v:
Journal of Adolescent Health. 71:239-241
The COVID-19 pandemic's impact on buprenorphine treatment for opioid use disorder among adolescents and young adults (AYAs) is unknown.We used IQVIA Longitudinal Prescription Claims, including US AYAs aged 12-29 with at least 1 buprenorphine fill bet
Publikováno v:
Addiction. 117:969-976
BACKGROUND AND AIMS Despite prescribing declines between 2011 and 2019, opioid morbidity and mortality in the United States continued to rise during this period. We estimated the relationship between opioid prescribing, opioid use disorder (OUD) and
Autor:
G. Caleb Alexander, Omar Mansour
Publikováno v:
JAMA. 328(19)
This Viewpoint discusses the settlement agreements reached against several major pharmaceutical distributors resulting from the US opioid epidemic and how those funds will be distributed amongst the states.
Autor:
Abdelrahman AlAshqar, Ryota Ishiwata, Chailee Moss, Kathleen M. Andersen, Lisa Yanek, Mark C. Bicket, G. Caleb Alexander, Mostafa A. Borahay
Publikováno v:
Am J Obstet Gynecol
Despite substantial reductions in the past decade, prescription opioids continue to cause widespread morbidity and mortality in the United States. Little is known regarding patterns and predictors of opioid use among women undergoing benign hysterect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c6a5330d87a43e065cd7099f981647
https://europepmc.org/articles/PMC9253094/
https://europepmc.org/articles/PMC9253094/
Autor:
Mark C. Bicket, Suzanne A. Nesbit, Susan Hutfless, Christopher L. Wu, Gabriel A. Brat, G. Caleb Alexander
Publikováno v:
American Journal of Health-System Pharmacy. 76:1403-1412
PurposeMillions of Americans who undergo surgical procedures receive opioid prescriptions as they return home. While some derive great benefit from these medicines, others experience adverse events, convert to chronic opioid use, or have unused medic
Publikováno v:
Medical Care. 57:667-672
BACKGROUND Although buprenorphine is an evidence-based treatment for opioid use disorder (OUD), it is unknown whether buprenorphine use may affect patients' adherence to treatments for chronic, unrelated conditions. OBJECTIVES To quantify the effect
Autor:
Brendan Saloner, Kelly E. Anderson, Julia Eckstein, G. Caleb Alexander, Sydney M. Dy, Lauren Niles, Sarah Hudson Scholle, Christine E. Chaisson
Publikováno v:
Med Care
AIMS: To characterize quality of buprenorphine care for opioid use disorder by quantifying buprenorphine initiation, engagement, and maintenance for individuals in a large, diverse, real-world cohort in the United States. DESIGN: Retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57eb2bbe06f39bc0ac13b88166fc687
https://europepmc.org/articles/PMC8026663/
https://europepmc.org/articles/PMC8026663/
Autor:
G. Caleb Alexander, Francis B. Palumbo, Eberechukwu Onukwugha, Beth Ann Griffin, Donna Harrington, Linda Simoni-Wastila, Patience Moyo
Publikováno v:
Health Serv Res
OBJECTIVE: To estimate the impact of implementing prescription drug monitoring program (PDMP) best practices on prescription opioid use. DATA SOURCES: 2007–2012 Medicare claims for noncancer pain patients, and PDMP attributes from the Prescription
Autor:
Kathryn Foti, Andrew Kolodny, Kristin Meek, James Heyward, Matthew Tajanlangit, G. Caleb Alexander, Christopher M. Jones
Publikováno v:
Drug and alcohol dependence. 225
Background Efforts to increase opioid use disorder (OUD) treatment have focused on primary care. We assessed primary care physicians’ preparedness to identify and treat individuals with OUD and barriers to increasing buprenorphine prescribing. Meth
Autor:
Omar Mansour, Francine Chingcuanco, G. Caleb Alexander, Ellen Hu, David W. Dowdy, Jeromie Ballreich, Harold A. Pollack
Publikováno v:
JAMA Netw Open
Importance The US opioid epidemic is complex and dynamic, yet relatively little is known regarding its likely future impact and the potential mitigating impact of interventions to address it. Objective To estimate the future burden of the opioid epid